Magellan Health Insights
  • Home
  • About
  • Resources
  • Voices
  • Contact

Groundbreaking Gene Therapy for Hemophilia — Magellan in the News

by Magellan Health Insights February 9, 2018Magellan Health

Magellan’s Haita Makanji, vice president, clinical specialty solutions, was featured in Managed Healthcare Executive this week, discussing some ground breaking new gene therapies that are available for hemophilia sufferers. These therapies promise the potential of fewer infusions and bleeding episodes.

You can read the complete article at Managed Healthcare Executive by clicking here.

Share on FacebookShare on TwitterShare on Linkedin
Tags: Gene Therapy, Gene Therapy for Hemophilia, Hemophilia, Magellan, Magellan Healthcare, Magellan in the News, Magellan RX, Magellan Rx Management, Managed Healthcare Executive
Magellan Health Insights
Previous post CAR-T Invoicing Construct: Specialty Pharmacy 2.0 Next post The future of work is not what it used to be (and it is already here)

Related Articles

Mental health parity

Celebrating 10 Years of Mental Health Parity

by Karen Amstutz
October 3, 2018
Small business start up team: briefing with notes

Managing Transformation Across Healthcare: Key Highlights from MOVE 2017

by Gus Giraldo
February 23, 2017
Work-Life-Family

The Juggle is Real

by Adam Weliver
October 31, 2017

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Magellan Health Logo

To learn more about how Magellan can support your organization, please visit MagellanHealth.com.

Topic suggestions or questions?
Send us your ideas at

Connect with us:

Trending Topics

  • A Present Day Look at PTSD
  • Medicine Cabinet Minefield: How old prescriptions drugs are fueling an opioid addiction crisis
  • The Trends and Complexities of Provider-Administered Drugs

Categories

Stay in the Know

Get the latest news and trending insights sent straight to your inbox.


HomeAboutResourcesVoicesContact
© 1999-2016 Magellan Health, Inc. All Rights Reserved.